BioSpace News Archive

Navitas Life Sciences, a TAKE Solutions Enterprise, announced the appointment of Dr. Steve Galen as the Global Head of Clinical.

Cynerio was founded by cybersecurity experts Leon Lerman and Daniel Brodie, CTO, to deliver a cybersecurity solution that is 100% designed for healthcare providers

Located on the third floor within the hospital, the center offers immediate 24/7 access to a complete array of medical and surgical services.

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the “Company” or “Canopy Growth”), through its Latin American-focused subsidiary, Canopy LATAM Corporation (“Canopy LATAM”), is proud to introduce Spectrum Cannabis Peru S.A.C. (“Spectrum Cannabis Peru”), the newest member of the growing global Spectrum Cannabis family.

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today provided a pipeline update and announced its 2019 financial guidance at the 37th annual JP Morgan Healthcare Conference.

Today, the Honourable Ginette Petitpas Taylor, Minister of Health, announced that the Government of Canada is launching a new financial support program for eligible Canadian thalidomide survivors

The new blood test, sclero-smart™, measures levels of anti-vinculin, recently found to be elevated in patients with scleroderma and associated with gastrointestinal complications.

ClearBalance records another strong year of growth for its patient financing solution in 2018

Green Relief Inc., Canada’s leading licensed producer of medical cannabis using aquaponics as a growing method, announced today that current CEO and co-founder of Green Relief, Warren Bravo, will be stepping down and welcoming John Durfy as interim CEO.

On the final day of the largest biotechnology and pharmaceutical partnering week at the Juvenescence Longevity Showcase two leading longevity biotechnology companies, Elevian and Insilico Medicine, announced a research and development partnership to develop oral medications targeting the GDF11 pathway and associated targets.